Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ClpX caseinolytic peptidase X homolog pseudogene (ENSG00000270470) is a nonfunctional, noncoding genomic sequence derived from duplication or retrotransposition of the functional CLPX gene (caseinolytic mitochondrial matrix peptidase chaperone subunit X)[2][4]. Pseudogenes like this one often retain high sequence similarity to their parent genes, but are rendered inactive by disabling mutations (frameshifts, stop codons, or regulatory disruptions). They generally do not produce functional proteins; however, in rare cases, some pseudogenes may be transcribed to RNA and exert regulatory effects on gene expression, typically in a locus-specific manner[2][6]. In summary, ENSG00000270470 is not a protein-coding gene, not a drug target, and does not possess typical molecular, biological, or disease associations outside its status as a pseudogene[2][4][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ClpX caseinolytic peptidase X homolog pseudogene.